4//SEC Filing
Colao Massimilano 4
Accession 0001628280-22-005124
CIK 0001600620other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:11 PM ET
Size
11.0 KB
Accession
0001628280-22-005124
Insider Transaction Report
Form 4
Colao Massimilano
Chief Commercial Officer
Transactions
- Award
Common Stock
2022-03-02+8,500→ 16,700 total - Sale
Common Stock
2022-03-02$12.01/sh−3,205$38,492→ 13,495 total - Award
Restricted Stock Unit
2022-03-02+104,080→ 104,080 total→ Common Shares (104,080 underlying) - Award
Stock Option (right to buy)
2022-03-02+178,063→ 178,063 totalExercise: $12.01Exp: 2032-03-02→ Common Stock (178,063 underlying)
Footnotes (4)
- [F1]On March 18, 2021, the Reporting Person was granted stock based performance awards ("Performance Awards") which vests when specific performance metrics are met based on the results for the year ended December 31, 2021. It was determined that as of March 2, 2022, the Reporting Person partially met the performance criteria and received shares of common stock for no consideration.
- [F2]Represents the number of shares sold to cover tax withholding obligations in connection with the vesting of Performance Awards.
- [F3]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning March 2, 2022, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date.
- [F4]One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.
Documents
Issuer
Aurinia Pharmaceuticals Inc.
CIK 0001600620
Entity typeother
Related Parties
1- filerCIK 0001837645
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:11 PM ET
- Size
- 11.0 KB